Stem Cell Therapy for Spinal Cord Injury
- Written by
- StemCell Longevita Editorial Team
- Medically reviewed by
- Prof. Dr. Erdal Karaöz TeamProfessor of Histology and Embryology · Medical Director, Center for Regenerative Medicine
- Last reviewed
- Next scheduled review
How we evaluate evidence · Conflict-of-interest disclosure · Editorial standards
Advanced MSC treatments promoting axonal regeneration, remyelination of damaged nerve fibers, and functional recovery below the injury level.
Can stem cell therapy help spinal cord injury?
Mesenchymal stem cell therapy is not an approved treatment for traumatic spinal cord injury. Early- and mid-phase trials — including intrathecal MSC studies in chronic injury — have reported acceptable safety but have not demonstrated a consistent, clinically meaningful improvement in ASIA motor or sensory scores. Neurorehabilitation, orthotic support and complication prevention remain the interventions with evidence.
Key facts
- Approval status
- Not approved for spinal cord injury
- Trial findings
- Safety acceptable; motor-score benefit not consistent
- Standard care
- Neurorehabilitation, orthotic support, complication prevention
What we know
- Intrathecal MSC administration has been studied in chronic SCI with short-term safety endpoints met.
What remains uncertain
- Whether any injury pattern or time-since-injury shows a reproducible ASIA improvement.
Medically reviewed questions
This summary is general medical information, not medical advice, and not a promise of benefit. Figures are quoted ranges, confirmed in writing after a medical review.
Medically reviewed by: Prof. Dr. Erdal Karaöz · Last updated: · Editorial and evidence policy
Evidence at a glance — Spinal cord injury
A plain summary of what the published research does and does not show for this condition. It is written to the same standard whether the evidence is strong or weak.
- Human studies available?
- Yes — early-stage only
- Randomised trials?
- A small number of randomised trials; most published work is uncontrolled
- Main outcomes studied
- ASIA impairment scale
- Sensory/motor levels
- Bladder and bowel function
- Safety
- Long-term evidence
- Very limited
- Regulatory approval for this indication
- United States (FDA): No FDA-approved mesenchymal stem cell product for this indication. The FDA has issued consumer warnings about unapproved stem cell products.
- European Union (EMA): No EMA-authorised mesenchymal stem cell medicine for this indication.
- United Kingdom (MHRA): No MHRA-authorised mesenchymal stem cell medicine for this indication.
- Türkiye (Ministry of Health): In Türkiye, cell therapies are delivered only inside Ministry of Health–licensed centres under the regenerative medicine / advanced therapy regulations, as clinical research or individual (exceptional) use — not as an approved routine treatment for this indication.
- Role at our centre
- Research context — considered only where standard care is exhausted or unsuitable, and never as a replacement for it
What kind of evidence exists
- Mechanism (laboratory): Documented
- Animal / preclinical: Documented
- Early human (phase 1/2, uncontrolled): Documented
- Controlled human (randomised or sham-controlled): Documented
- Regulatory approval: Not established
Sources
- Systematic reviews and meta-analyses — Spinal cord injury — PubMed
- Randomised controlled trials — Spinal cord injury — PubMed
- Registered MSC trials — Spinal cord injury — ClinicalTrials.gov
- FDA — Consumer alert on regenerative medicine therapies — U.S. Food and Drug Administration, 2024
- Advanced therapy medicinal products: overview — European Medicines Agency, 2025
- ISSCR Guidelines for Stem Cell Research and Clinical Translation — International Society for Stem Cell Research, 2021
- ISSCR Patient Handbook on Stem Cell Therapies — International Society for Stem Cell Research, 2020
Source links open filtered searches of PubMed and ClinicalTrials.gov plus regulator and professional-society pages, so you can read the current evidence yourself rather than a selected extract.
This summary is general information about the evidence base, not medical advice and not a promise of benefit. Whether any treatment is appropriate for you can only be decided after a medical review of your records.
What is Spinal Cord Injury?
Spinal cord injury (SCI) occurs when damage to the spinal cord results in temporary or permanent loss of motor function, sensation, or autonomic function below the level of injury. Worldwide, between 250,000 and 500,000 people suffer spinal cord injuries each year.
Traditional medicine has limited options for SCI recovery beyond stabilization surgery and rehabilitation. Stem cell therapy offers new hope by promoting neural regeneration, remyelination of damaged nerve fibers, and modulation of the hostile injury environment to support functional recovery.
At StemCell Longevita, our specialized SCI protocols use intrathecal MSC delivery combined with IV administration to maximize therapeutic potential, with treatment protocols developed alongside leading neurorehabilitation specialists.
Ideal Candidates
- Patients with incomplete or complete spinal cord injuries
- Both acute (recent) and chronic spinal cord injury patients
- Patients with paraplegia or quadriplegia seeking functional improvement
- Those experiencing sensory or motor deficits below injury level
- Patients who have stabilized post-surgery and completed initial rehabilitation
How Stem Cell Therapy Helps Spinal Cord Injury
Axonal Regeneration
MSCs secrete neurotrophic factors that promote the regrowth of damaged axons and the formation of new neural circuits across the injury site.
Remyelination
Stem cells support the regeneration of myelin sheaths around damaged nerve fibers, restoring electrical signal transmission efficiency.
Anti-Scarring Effects
MSCs modulate the glial scar formation at the injury site, creating a more permissive environment for nerve regeneration and recovery.
Sensory & Motor Gains
Many patients experience improvements in sensation, muscle strength, bladder/bowel function, and voluntary movement below the injury level.
Treatment Process
Your step-by-step treatment journey at StemCell Longevita
Comprehensive SCI Evaluation
ASIA impairment scale assessment, MRI evaluation of injury site, electrophysiology studies, and functional capacity review.
Protocol Design
Individualized treatment plan based on injury level, completeness, duration since injury, and current functional status.
MSC Preparation
High-potency Wharton's jelly MSCs prepared with 97% viability, optimized for neural repair applications.
Targeted Delivery
Intrathecal injection near the injury site combined with IV infusion for systemic neuroprotection.
Rehabilitation Integration
Post-treatment rehabilitation program coordination, progress evaluation at regular intervals, and follow-up treatment planning.
Patient Experiences
Real outcomes from patients who chose regenerative medicine at StemCell Longevita Istanbul
"After 8 years of decline, I finally feel like I'm moving forward again. The team in Istanbul gave me something my neurologist at home couldn't — hope backed by real results."
"Within three months of treatment, our daughter started calling us by name. Her teachers noticed the difference before we even told them about the therapy."
Frequently Asked Questions
All Regenerative Medicine Applications
Explore our comprehensive range of regenerative medicine applications for various conditions. Click any option to learn more.
Related Articles
Explore our in-depth research articles and guides on related treatments and therapies.
Cerebral Palsy & Regenerative Medicine: New Hope for Children
Discover how mesenchymal stem cell approaches are supporting the care landscape for cerebral palsy, offering potential motor function improvement and quality of life for children and families worldwide.
Read ArticleRegenerative Medicine Application for Autism Spectrum Disorder
Explore the promising potential of regenerative medicine in addressing autism spectrum disorder symptoms, including potential improvements in communication, social interaction, and behavioral patterns.
Read ArticleStroke Progress: How Stem Cells Support Neurological Wellness
Exploring the potential of regenerative medicine in stroke rehabilitation, including mechanisms of action and reported improvements in motor and cognitive function.
Read ArticleRelated clinical questions
Where this page sits in the wider picture.